Simplified and accelerated research workflow including high-quality DNA extraction kits, library preparation for whole genome metagenomics, and user-friendly bioinformatics analysis // Workflow ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis ...
QIAGEN N.V. QGEN recently announced the launch of the Microbiome WGS (whole-genome sequencing) SeqSets — a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that ...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the global launch of QIA Agent, an AI-powered digital ...
Zacks Investment Research on MSN
QIAGEN stock up on the launch of AI-powered workflow agent platform
QIAGEN QGEN recently launched QIA Agent, an AI-powered digital assistant designed to simplify how researchers plan ...
AI-enabled risk stratification tool for TB progression targeted for late 2027 launch, designed to support all QuantiFERON customers with informed clinical decision-making for patient care QIAGEN and ...
Fully automated workflow targeted for late 2027 launch integrates QuantiFERON test, Diasorin LIAISON systems, and purpose-built end-to-end automation from new Inpeco partnership AI-enabled risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results